Notes And Other Explanatory Information [Abstract]

Mowi ASA - Filing #2585061

Concept	2022-01-01 to 2022-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]	NOTE 3A - ESTIMATES AND JUDGEMENTS
Disclosure of accrued expenses and other liabilities [text block]	NOTE 18 - TRADE PAYABLES AND OTHER CURRENT LIABILITIES
Disclosure of allowance for credit losses [text block]	MOVEMENT IN PROVISIONS FOR CREDIT LOSSES (TRADE RECEIVABLES)
Disclosure of associates [text block]	NOTE 21 - INVESTMENTS IN ASSOCIATED COMPANIES AND INTEREST IN JOINT VENTURES
Disclosure of auditors' remuneration [text block]	NOTE 32 - AUDITOR’S FEES
Disclosure of authorisation of financial statements [text block]	The financial statements were authorised by the Board of Directors on
Disclosure of basis of consolidation [text block]	CONSOLIDATION
Disclosure of biological assets, agriculture produce at point of harvest and government grants related to biological assets [text block]	NOTE 6 - BIOLOGICAL ASSETS
Disclosure of borrowing costs [text block]	The following programmes are the main sources of financing for the Mowi Group as of
Disclosure of borrowings [text block]	NOTE 11 - INTEREST-BEARING DEBT
Disclosure of business combinations [text block]	NOTE 22 - BUSINESS COMBINATIONS, ASSETS HELD FOR SALE AND DISCONTINUED OPERATIONS
Disclosure of cash and cash equivalents [text block]	NOTE 16 - CASH
Disclosure of cash flow statement [text block]	CASH MOVEMENTS FINANCING ACTIVITIES
Disclosure of changes in accounting policies, accounting estimates and errors [text block]	NOTE 33 - NEW IFRS STANDARDS
Disclosure of collateral [text block]	NOTE 19 - SECURED LIABILITIES AND GUARANTEES
Disclosure of commitments [text block]	Contractual commitments
Disclosure of contingent liabilities [text block]	NOTE 27 - CONTINGENT LIABILITIES AND PROVISIONS
Disclosure of credit risk [text block]	CREDIT RISK
Disclosure of deferred taxes [text block]
Disclosure of derivative financial instruments [text block]
Disclosure of dividends [text block]	LEVERAGE AND CAPITAL ACCESS
Disclosure of earnings per share [text block]	NOTE 25 - EARNINGS PER SHARE
Disclosure of employee benefits [text block]	NOTE 14 - REMUNERATION
Disclosure of entity's operating segments [text block]	NOTE 4 - BUSINESS SEGMENTS
Disclosure of events after reporting period [text block]	NOTE 34 - SUBSEQUENT EVENTS
Disclosure of fair value measurement [text block]	FAIR VALUE OF FINANCIAL INSTRUMENTS
Disclosure of financial instruments [text block]	NOTE 12 - FINANCIAL INSTRUMENTS
Disclosure of financial instruments at fair value through profit or loss [text block]
Disclosure of financial risk management [text block]	FINANCIAL RISK MANAGEMENT
Disclosure of general information about financial statements [text block]	NOTE 1 - GENERAL INFORMATION
Disclosure of impairment of assets [text block]	NOTE 8 - IMPAIRMENT TESTING OF INTANGIBLE ASSETS
Disclosure of income tax [text block]	NOTE 15 - TAXES
Disclosure of information about key management personnel [text block]
Disclosure of intangible assets [text block]	NOTE 9 - INTANGIBLE ASSETS
Disclosure of inventories [text block]	NOTE 7 - INVENTORY
Disclosure of issued capital [text block]	NOTE 24 - SHARE CAPITAL
Disclosure of leases [text block]	NOTE 29 - LEASES
Disclosure of liquidity risk [text block]	PRICE/LIQUIDITY RISK
Disclosure of market risk [text block]	CURRENCY RISK
Disclosure of non-current assets held for sale and discontinued operations [text block]	ASSETS HELD FOR SALE
Disclosure of objectives, policies and processes for managing capital [text block]	NOTE 13 - CAPITAL MANAGEMENT AND RISK MANAGEMENT
Disclosure of other non-current liabilities [text block]	NOTE 20 - OTHER NON-CURRENT LIABILITIES
Disclosure of other operating expense [text block]	NOTE 28 - OTHER OPERATING EXPENSES
Disclosure of property, plant and equipment [text block]	NOTE 10 - PROPERTY, PLANT AND EQUIPMENT
Disclosure of related party [text block]	NOTE 26 - RELATED PARTY TRANSACTIONS
Disclosure of research and development expense [text block]	NOTE 31 - RESEARCH AND DEVELOPMENT
Disclosure of revenue [text block]	NOTE 5 - DISAGGREGATION OF REVENUE
Disclosure of share-based payment arrangements [text block]	SHARE OPTION SCHEME
Disclosure of subsidiaries [text block]	NOTE 23 - CONSOLIDATED ENTITIES
Disclosure of tax receivables and payables [text block]
Disclosure of trade and other receivables [text block]	NOTE 17 - TRADE RECEIVABLES, OTHER RECEIVABLES AND PREPAYMENTS